Assist Prof Dr Mohamed Lemine Cheikh Brahim Ahmed | HPV | Best Researcher Award

Posted on by Pencis

Assist Prof Dr Mohamed Lemine Cheikh Brahim Ahmed | HPV | Best Researcher Award

University of Nouakchott | Mauritania

Author Profile

Scopus

ORCID ID

Dr. Mohamed Lemine Cheikh Brahim Ahmed

🎓Education :

  • PhD in Public Health 🧬
    Université Mohammed V, Rabat, Morocco
  • Master of Public Health in Molecular Epidemiology of Zoonotic Diseases 🦠🔬
    IAV Hassan II, Rabat, Morocco
  • Certificate in Molecular Biology and Bioinformatics 🧬💻
    Hua Zhong Normal University, Wuhan, China

🌍Professional Memberships :

  • Member of the World Society for Virology (WSV) 🧫
  • Member of the International Covid-19 Research Network (ICRN) 🦠
  • Member of the One Health Heukelbach Institute 🌱
  • Member of the MENA Coalition for HPV Elimination 💉
  • Member of the Research Unit on Molecular Epidemiology and Microorganism Diversity (EMDM) 🧬
  • President of the Mauritanian Society for Scientific Research (AMDRS) 🧑‍🔬
  • Collaborator on the Global Burden of Diseases (GBD) project, Institute for Health Metrics and Evaluation, University of Washington 🌎

💡Key Skills :

  • Vaccine Coordination & Logistics 🚚💉:

  • Planned and supervised vaccine logistics for remote regions in Mauritania, ensuring stock management and quality control practices for vaccines like PCV13 and Rotarix.

  • Public Health Communication & Training 📢👩‍⚕️:

  • Conducted team-building and training sessions for local health personnel, focusing on routine and Covid-19 vaccination campaigns.

  • Research Project Management 🧑‍🔬📊:

  • Led public health research projects, managing performance indicators, and reporting on vaccine distribution and health systems.

  • Flexibility & Versatility ⚙️:

  • Adapted to various challenges in vaccine distribution and epidemiological surveillance, especially during pandemics.

✅Main Qualifications :

Vaccination 💉:

  • Supervised and trained local teams for stock management and quality control of vaccines across remote areas in Mauritania.
  • Led national Covid-19 vaccination strategy development, training teams and evaluating the impact of vaccine introductions (e.g., PCV13, Rotarix).
  • Coordinated routine vaccination campaigns across all 15 regions of Mauritania and introduced critical vaccines like nVPO2 for polio.

Epidemiological Surveillance 🧬:

  • Developed and implemented national strategies for combatting Covid-19, including plans for testing diseases like measles, polio, hemorrhagic fevers, and HPV.
  • Organized and led sentinel surveillance programs for diseases like rotavirus and influenza.
  • Conducted performance evaluations of Mauritania’s health information systems and trained response teams for integrated epidemiological surveillance.

🏢Recent Professional Experience :

National Consultant

UNICEF, Mauritania (Feb 2022 – Jul 2022)
Supported cold chain logistics and vaccine management for poliomyelitis response campaigns. Key tasks included overseeing vaccine distribution, supporting data analysis, and participating in meetings for budget planning with GPEI.

  • Provided technical assistance for vaccine logistics, ensuring the collection and destruction of unusable vaccine vials.
  • Led training sessions for independent monitors and LQAS surveyors to evaluate the polio vaccination campaign.

📈 Conclusion🌟

Dr. Mohamed Lemine Cheikh Brahim Ahmed is a highly skilled expert in vaccination logistics and epidemiological surveillance 🦠💉, with extensive experience in public health, research management, and disease control. His work spans from developing national vaccination strategies, including Covid-19, to training teams and overseeing campaigns in remote regions of Mauritania. As a member of numerous global health organizations 🌍 and a key contributor to projects like the Global Burden of Diseases 🌎, he is committed to improving public health outcomes through innovative approaches and evidence-based strategies. Dr. Ahmed’s versatility, leadership, and dedication make him a valuable asset in the field of global health and vaccination efforts.

📊🔬NOTABLE PUBLICATION:

 

    • Article: Quantifying risks and interventions that have affected the burden of diarrhoea among children younger than 5 years: an analysis of the Global Burden of Disease Study 2017
      • Authors: Troeger, C.E., Khalil, I.A., Blacker, B.F., Hay, S.I., Reiner, R.C.
      • Journal: The Lancet Infectious Diseases
      • Year: 2020

     

    • Article: Quantifying risks and interventions that have affected the burden of lower respiratory infections among children younger than 5 years: an analysis for the Global Burden of Disease Study 2017
      • Authors: Troeger, C.E., Khalil, I.A., Blacker, B.F., Hay, S.I., Reiner, R.C.
      • Journal: The Lancet Infectious Diseases
      • Year: 2020

     

    • Article: The global case fatality rate of coronavirus disease 2019 by continents and national income: A meta-analysis
      • Authors: Abou Ghayda, R., Lee, K.H., Han, Y.J., Smith, L., Shin, J.I.
      • Journal: Journal of Medical Virology
      • Year: 2022

     

    • Article: Nonpharmaceutical interventions reduce the incidence and mortality of COVID-19: A study based on the survey from the International COVID-19 Research Network (ICRN)
      • Authors: Park, S.H., Hong, S.H., Kim, K., Il Shin, J., Smith, L.
      • Journal: Journal of Medical Virology
      • Year: 2023

     

    • Article: COVID-19 outbreak in Mauritania: Epidemiology and health system response
      • Authors: Ahmed, M.L.C.B., Zehaf, S., El Alem, M.M., Abdellahi, M.V.M., Heukelbach, J.
      • Journal: Journal of Infection in Developing Countries
      • Year: 2021

Dr. Luguterah Austin Wontepaga | Sports | Best Researcher Award

Posted on by Pencis

Dr. Luguterah Austin Wontepaga | Sports | Best Researcher Award

University Of Ghana | Ghana 

AUTHOR PROFILE

Google Scholar

ORCID ID

DR. LUGUTERAH AUSTIN WONTEPAGA: UNIVERSITY OF GHANA SPORTS EXPERT

📚EARLY ACADEMIC PURSUITS 

Dr. Luguterah Austin Wontepaga began his academic journey with a strong foundation in sports policy and public administration. He earned his PhD in Public Administration, with a focus on Sports Policy, from the University of South Africa. His early education fostered his interest in how sports intersect with administration and governance, paving the way for his impactful career.

🏆PROFESSIONAL ENDEAVORS 

Dr. Wontepaga is a Senior Lecturer and Head of the Department of Physical Education and Sport Studies at the University of Ghana. In addition to his academic role, he actively participates in the sports world as the Vice President of the Ghana Volleyball Association and Chairman of the Development Commission for the Confederation of African Volleyball-Zone 3. His professional work goes beyond teaching, with significant involvement in the development and management of sports at national and continental levels.

🧐CONTRIBUTIONS AND RESEARCH FOCUS 

Dr. Wontepaga’s research interests are rooted in sports for development, sports policy, sports coaching, and sports management. He has contributed substantially to understanding how sports can drive development, especially in Africa. His research includes extensive peer-reviewed journal articles, and he has undertaken significant projects that impact the formulation of sports policies in Ghana and beyond.

🌍IMPACT AND INFLUENCE 

As a key figure in Ghana’s sports landscape, Dr. Wontepaga has played a pivotal role in shaping sports education and policy. His work emphasizes using sports as a tool for social and economic development, particularly focusing on the role of sports in youth empowerment and community cohesion. His leadership within African volleyball extends his influence across the continent, contributing to the growth of the sport at both grassroots and elite levels.

📜ACADEMIC CITATIONS AND RECOGNITION 

Dr. Wontepaga has authored numerous peer-reviewed journal articles, many of which have been widely cited within the academic community. His research has influenced policies and practices related to sports development, earning him recognition both locally and internationally. His academic contributions are regularly referenced by scholars and policymakers in the field of sports management.

🏅LEGACY AND FUTURE CONTRIBUTIONS 

Dr. Luguterah Austin Wontepaga’s legacy in the sports and academic communities is already well established. His work in sports policy and development is creating lasting change in how sports are used to foster development and education. Moving forward, his continued leadership at the University of Ghana and in various sporting organizations is expected to drive innovation and growth, especially in sports management and coaching education. His future contributions will likely focus on expanding the role of sports as a developmental tool across Africa, ensuring that sports remain a key element in youth development and policy formulation.

💡FINAL THOUGHTS 

Dr. Wontepaga is a dynamic figure in sports academia and leadership. His work not only strengthens Ghana’s sports education framework but also influences broader sports policy on the African continent. His dedication to sports development, research, and policymaking ensures his impact will be felt for generations to come.

📈 CONCLUSION 🌟

Dr. Luguterah Austin Wontepaga stands as a key figure in sports academia, policy, and development both in Ghana and across Africa. His profound contributions through teaching, research, and leadership have reshaped the landscape of sports education and management. His work in using sports as a vehicle for social and economic development showcases his commitment to empowering communities and advancing youth potential. As he continues to influence sports policy and development, his legacy is firmly established, and his future contributions are set to further elevate sports as a critical tool for African development. Dr. Wontepaga’s impact on academia, sports governance, and youth empowerment will undoubtedly leave a lasting mark on both the academic world and the sporting community.

📊🔬NOTABLE PUBLICATION:

 

    • Exploration of science teaching self-efficacy outside professional development context for inquiry-based teaching
      • Authors: Salifu Maigari Mohammed, Austin Wontepaga Luguterah
      • Journal: Cogent Education
      • Year: 2024

     

    • The capabilities of sports as an option for poverty reduction strategy: Citizen perspective
      • Authors: Austin Wontepaga Luguterah, Salifu Maigari Mohammed, Daniel Apaak, Richard Samuel Kwadwo Abieraba
      • Journal: Journal of Community & Applied Social Psychology
        Year: 2024

     

    • Exploration of Science Teaching Self-Efficacy Sources from Multiple Narratives of Professional Development Experiences
      • Authors: Salifu Maigari Mohammed, Austin Wontepaga Luguterah
      • Journal: African Journal of Empirical Research
      • Year: 2024

     

    • Interaction Between Coaches and Athletes in African Nations During the Lockdown Period of COVID-19
      • Authors: Austin W Luguterah, Usman Abonyi, Rita Yeboah, Alliance Kubayi
      • Journal: International Sport Coaching Journal
      • Year: 2023

     

    • Motivations of pre-service teachers in the colleges of education in Ghana for choosing teaching as a career
      • Authors: Usman Kojo Abonyi, Doreen Awhireng, Austin Wontepaga Luguterah
      • Journal: Cogent Education
      • Year: 2021

Dr. Pengchong Wang | Cancer Therapy | Best Researcher Award

Posted on by Pencis

Dr. Pengchong Wang | Cancer Therapy | Best Researcher Award

Shaanxi Provincial People’s Hospital | China

AUTHOR PROFILE

Scopus

💊 WANG PENGCHONG: ACADEMIC PROFILE AND ACHIEVEMENTS 🎓

🎓EARLY ACADEMIC PURSUITS 📚

Wang Pengchong, the Chief Pharmacist at Shaanxi Provincial People’s Hospital, earned his PhD in Pharmacy from Xi’an Jiaotong University. His academic journey was shaped by a focus on tumor pharmacy and targeted drug delivery systems. His early years were spent delving into the intricacies of pharmaceutical care, particularly in the context of oncology, laying the foundation for his future breakthroughs.

💼 PROFESSIONAL ENDEAVORS 🏥

Wang is a dedicated member of the Pharmaceutical Care Committee of the Shaanxi Pharmacological Society. His professional work has revolved around tumor pharmacology, pioneering approaches to targeted cancer treatments. He has played an instrumental role in several major projects, including three general projects funded by the National Natural Science Foundation of China and two key R&D projects in Shaanxi Province. His leadership in high-profile initiatives highlights his influence on pharmaceutical advancements.

🔬 CONTRIBUTIONS AND RESEARCH FOCUS 🎯

Wang Pengchong’s research is centered on targeted drug delivery systems and tumor pharmacy research. His contributions are geared toward improving cancer therapies by focusing on precision medicine, which minimizes side effects and enhances the effectiveness of treatment. His work extends into innovative methods, such as nanotechnology in drug targeting. Wang has led multiple significant projects, including the Shaanxi Province Science and Technology Plan Project, the Xi’an City Science and Technology Plan Project, and the Yaodong Shenzhou Pharmaceutical Research Capacity Building Project.

✨ IMPACT AND INFLUENCE 🌐

Wang’s research has had a profound impact on cancer treatment strategies and pharmaceutical care. His efforts have advanced both the scientific understanding and practical application of cancer drugs, particularly in how they can be precisely targeted to tumor cells while sparing healthy tissues. Through his leadership in government-backed research initiatives, Wang has become a driving force in the field, influencing not just Shaanxi Province but the broader pharmaceutical landscape.

📊 ACADEMIC CITES 📄

In the past five years, Wang Pengchong has published more than ten SCI-indexed papers in international journals. His work is widely cited, particularly in oncology and pharmaceutical sciences. His research topics span from cutting-edge drug delivery systems to therapeutic advancements, solidifying his reputation in the global scientific community.

🌍 LEGACY AND FUTURE CONTRIBUTIONS 🏆

Wang Pengchong’s legacy will continue to grow as he contributes to targeted cancer therapies and pharmaceutical innovations. His role in advancing precision medicine ensures that his work will influence the next generation of cancer treatments. By leading critical projects and setting new benchmarks in oncology pharmacy, Wang is shaping the future of drug delivery systems and cancer care. His ongoing commitment to pharmaceutical research guarantees that his contributions will leave a lasting impact on the field.

📈 CONCLUSION 🌟

Wang Pengchong’s distinguished career as a Chief Pharmacist and researcher has made significant strides in the fields of targeted drug delivery systems and tumor pharmacy. His academic foundation, coupled with leadership in high-impact research projects, has not only advanced cancer treatment but also positioned him as a key contributor to pharmaceutical sciences. With over a decade of impactful publications and successful project leadership, Wang’s research continues to shape the future of oncology treatments, fostering innovations that will benefit patients worldwide. His work embodies a lasting legacy of precision medicine and cutting-edge cancer therapies, ensuring he remains a pivotal figure in pharmaceutical research and development. 🌍🔬

 

📊🔬NOTABLE PUBLICATION:

 

    • Mucoadhesive nanoparticles-based oral drug delivery systems enhance ameliorative effects of low molecular weight heparin on experimental colitis
      • Authors: Yan, Y., Sun, Y., Wang, P., Xing, J., Dong, Y.
      • Journal: Carbohydrate Polymers
      • Year: 2020

     

    • An improved synthesis of water-soluble dual fluorescence emission carbon dots from holly leaves for accurate detection of mercury ions in living cells
      • Authors: Wang, P., Yan, Y., Zhang, Y., Xing, J., Dong, Y.
      • Journal: International Journal of Nanomedicine
      • Year: 2021

     

    • One-pot synthesis of nuclear targeting carbon dots with high photoluminescence
      • Authors: Wang, P., Ji, H., Guo, S., Xing, J., Dong, Y.
      • Journal: Chinese Chemical Letters
      • Year: 2021

     

    • Hyaluronic acid-based M1 macrophage targeting and environmental responsive drug releasing nanoparticle for enhanced treatment of rheumatoid arthritis
      • Authors: Wang, P., Zhang, Y., Lei, H., Xing, J., Dong, Y.
      • Journal: Carbohydrate Polymers
      • Year: 2023

     

    • Multifunctional nanosystems sequentially regulating intratumor Fenton chemistry by remodeling the tumor microenvironment to reinforce chemodynamic therapy
      • Authors: Dong, K., Chen, W., Zhao, Z., Lu, T., Dong, Y.
      • Journal: Biomaterials Advances
      • Year: 2022

Mrs. Anke van Engen | Clinical Health Technology | Best Researcher Award

Posted on by Pencis

Mrs. Anke van Engen | Clinical Health Technology | Best Researcher Award

IQVIA | Netherlands 

Author Profile

Scopus

🌍Mrs. Anke van Engen 💼

  • Managing Principal, IQVIA Payer Evidence Solutions
    Amsterdam, the Netherlands

🔬Profile:

  • Anke van Engen is a seasoned expert with over 20 years of experience in health economics, outcomes research, and market access strategy. Her work focuses on helping life sciences companies achieve greater commercial success through integrated payer evidence strategies. Anke is well-regarded for building lasting partnerships, consistently delivering results, and serving as a trusted advisor to clients. She excels at leading international teams across EMEA, using her coaching and training abilities to inspire success.

👨‍⚕️Key Specialties:

  • 📚General management
  • 🌍Strategic planning & business development
  • 🩺Health economics & outcomes research (HEOR)
  • 🏥Market access strategy (MA) & execution
  • 💉Health technology assessment (HTA)
  • 📍Client relationship management & coaching

💼Professional Experience:

  • 🌟2023 – Present: Managing Principal, IQVIA Value & Payer Evidence
    • Co-leads EMEA Real World Evidence Leadership Team
    • Oversees integrated evidence & EU HTA offerings
  • 💡2020 – 2023: Senior Principal, IQVIA Real World Solutions
    • Led the development of EMEA payer evidence solutions
    • Drove go-to-market strategy and key client partnerships
  • 🌐2017 – 2020: Senior Principal, IQVIA Consulting Services
    • Managed partnerships with large pharmaceutical clients
    • Led the HTA Accelerator solution for launch readiness
  • 🚀2014 – 2017: Principal, Quintiles Advisory Services
    • Led development of the flagship HTA Accelerator platform
    • Senior oversight on HEOR/MA strategy and projects

🎓Education:

  • 🧪MSc in Chemistry (Bio-organic Chemistry), University of Leiden, The Netherlands
  • 📊Business leadership programs at IMD, Lausanne, Switzerland

🌐Professional Affiliations:

  • 🧬Active member of ISPOR and HTAi
  • 💡IQVIA representative at GetReal Institute

🏅Awards & Honors:

  • 🌟2023: Issue panel ranked #1 at ISPOR Europe
  • 🦈2014: Won Sharktank contest for HTA Accelerator innovation
  • 🏆Multiple ISPOR awards for best podium and poster presentations

 

🔍 Conclusion
  • 💼In conclusion, Anke van Engen is a highly respected leader in the field of health economics, outcomes research, and market access strategy, with a proven track record of guiding life sciences companies toward commercial success. Her expertise in building long-term client partnerships, managing international teams, and delivering innovative payer evidence solutions has solidified her reputation as a trusted advisor. With over two decades of experience and numerous accolades, Anke continues to shape the future of healthcare consultancy by integrating strategic insights and real-world evidence. 🌍

 

📊🔬NOTABLE PUBLICATION:

 

    • The Impact of Additive PICOs in a European Union Joint Clinical Health Technology Assessment
      • Authors: van Engen A, Krüger R, Parnaby A, Rotaru M, Ryan J, Samaha D, Tzelis D
      • Journal: Value Health
      • Year: 2024

     

    • Use of External Comparators for Health Technology Assessment (HTA) Submissions Based on Single-Arm Trials
      • Authors: Patel D, Grimson F, Mihaylova E, Wagner P, Warren J, van Engen A, Kim J
      • Journal: Value Health
      • Year: 2021

     

    • Call in the PROs: Giving Credence to the Patient’s Perspective in Healthcare Decision Making
      • Authors: van Engen A, New M, Beatrice Böhler Y, Holmstrom S, Boerlum Kristensen F
      • Journal: ISPOR Value & Outcomes Spotlight
      • Year: 2020

Dr Ghanshyam Ghelani | Bladder Cancer | Best Researcher Award

Posted on by Pencis

Dr Ghanshyam Ghelani | Bladder Cancer | Best Researcher Award

SUNY Upstate Medical University | United States 

Author Profile

Scopus

ORCID Id

🩺Ghanshyam Ghelani, MD 💉

Hematology-Oncology Fellow & Clinical Investigator
SUNY Upstate Medical University, Syracuse, NY

🎓 Education

  • M.B.B.S. – B.J. Medical College, Ahmedabad, Gujarat, India (09/2002 – 03/2008)
    📚 Ranked in the top 10% of a class of 250 students.
  • Internal Medicine Residency – The Wright Center for Graduate Medical Education, Scranton, PA, USA (07/2013 – 06/2016)
    🏥 Completed residency at affiliate hospitals including Geisinger CMC and VA Medical Center.
    🏅 Awarded M.D. by New York State on November 16, 2016.
  • Hematology-Oncology Fellowship – SUNY Upstate Medical University, Syracuse, NY (07/2021 – 06/2024)
    💉 Active Member of the Transfusion Medicine Committee and Hematology-Oncology Representative of the Resident and Fellow Forum.

💼 Certifications and Licensure

  • Board Certification – The American Board of Internal Medicine
  • State License – New York: Full License # 285166
  • DEA Registration – FG6123385
  • Advanced Cardiac Life Support (ACLS) – Re-Certified on 10/09/2021

🌐 Professional Memberships

  • 👨‍⚕️ Member, American College of Physicians
  • 🇮🇳 Life Member, Gujarat Medical Council
  • 🩺 Member, American Medical Association (AMA)
  • 🧬 Member, American Society of Clinical Oncology (ASCO)
  • 🌍 Member, European Society for Medical Oncology (ESMO)
  • 🩸 Member, American Society of Hematology (ASH)

🔬 Research and Academic Work

Assistant Professor of Medicine & Clinical Investigator
SUNY Upstate Medical University (07/2016 – 06/2021)

  • Key Research Projects
    • 🧬 HPV-Positive Clinically Advanced Bladder Squamous Cell Carcinoma (aBSCC): Analyzed genomic alterations associated with HPV.
    • 🧑‍🔬 Metabolic Syndrome & Immunotherapy in NSCLC: Studied the impact of metabolic syndrome on outcomes with immune checkpoint inhibitors in non-small cell lung cancer (NSCLC).
    • 🩸 Peripheral Blood Biomarkers in Metastatic Melanoma: Identified biomarkers for treatment response and immune-related adverse events in patients treated with immunotherapy for stage-IV melanoma.

🏅 Awards

  • Ranked in the top 10% of the class during medical school. 🎖️

Dr. Ghanshyam Ghelani is a dedicated Hematology-Oncology fellow with expertise in internal medicine and a strong background in cancer research, particularly in genomic profiling, immunotherapy, and biomarker discovery. 🧬💡

 

🔍 Conclusion

Dr. Ghanshyam Ghelani is a highly accomplished medical professional, currently advancing his expertise as a Hematology-Oncology Fellow at SUNY Upstate Medical University. With a strong foundation in internal medicine and an impressive portfolio of research in cancer treatment and immunotherapy, Dr. Ghelani has made significant contributions to the field of oncology. His active involvement in professional societies and dedication to exploring novel cancer therapies highlight his commitment to improving patient outcomes through cutting-edge research and clinical practice. Dr. Ghelani’s journey reflects a deep passion for medicine, research, and innovation in cancer care. 💉🧬🌟

 

📊🔬NOTABLE PUBLICATION:

 

    • Radioimmunoconjugates in the Age of Modern Immuno-Oncology
      • Authors: Nasr, D., Kumar, P.A., Zerdan, M.B., Graziano, S., Lim, S.H.
      • Journal: Life Sciences
      • Year: 2022

     

    • HPV-Positive Clinically Advanced Squamous Cell Carcinoma of the Urinary Bladder (aBSCC): A Comprehensive Genomic Profiling (CGP) Study
      • Authors: Ghelani, G.H., Zerdan, M.B., Jacob, J., Bratslavsky, G., Basnet, A.
      • Journal: Urologic Oncology: Seminars and Original Investigations
      • Year: 2023

     

    • Breast Cancer Treatment: To Target or Not? That Is the Question
      • Authors: Stone, A., Lin, K.M., Ghelani, G.H., Graziano, S., Kotula, L.
      • Journal: Cancers
      • Year: 2023

     

    • Hematologic Abnormalities After COVID-19 Infection: A Case of Coombs-Negative Hemolytic Anemia and Thrombocytopenia
      • Authors: Siegenthaler, A.G., Ghelani, G., Brady, A., Loon, T., Madhira, B.R.
      • Journal: Journal of Investigative Medicine High Impact Case Reports
      • Year: 2023

     

    • Metabolic Syndrome Is Independently Associated with Improved Overall Survival to First-Line Therapy with Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer
      • Authors: Bou Zerdan, M., Ashok Kumar, P., Barrios, D.M., Graziano, S., Lim, S.H.
      • Journal: Frontiers in Oncology
      • Year: 2023

Ms. Xiaorong Zhu | Multiple Myeloma | Best Researcher Award

Posted on by Pencis

Ms. Xiaorong Zhu | Multiple Myeloma | Best Researcher Award

Baotou Medical College of Inner Mongolia University of Science and Technology | China

Author Profile

ORCID Id

👩‍⚕️💉Xiaorong Zhu: Aspiring Internal Medicine Physician 

🎓 Education Experience

  • 🎓2016.09-2021.07: Bachelor’s in Clinical Medicine
    Baotou Medical College, Inner Mongolia University of Science and Technology
  • 🏥2021.09-2024.07: Master’s in Internal Medicine
    Baotou Medical College, Inner Mongolia University of Science and Technology

🩺 Internship Experience

  • 🏨2019.08-2021.07: Baotou City Central Hospital (Fieldwork)
    • 🏥Completed rotations in Internal Medicine, Surgery, Obstetrics & Gynecology, and Emergency Department.
    • ⚕️Gained practical experience diagnosing and treating common diseases.
  • 🩺2021.09-2024.07: Baotou City Central Hospital (Resident Training)
    • 💉Participated in over 100 clinical cases, working closely with senior physicians.
    • 🔬Skilled in bone marrow punctures, biopsies, and other key clinical procedures.

🎯 School Experience

  • 🎓2016.09-2021.07: Undersecretary, Student Union of Central Clinical Medical School
    • 📚Organized medical seminars, attracting over 200 participants.
    • 🩺👩‍⚕️Coordinated clinical skills workshops, helping 100 students improve their skills.
    • 🤝💡Led volunteer projects, involving 300 student volunteers.

🏆 Relevant Skills

  • 📜Certified in Standardized Resident Training (Internal Medicine)
  • 📖Fluent in English (CET-4), with strong reading and writing abilities
  • ✍️Holder of Internal Medicine Qualification & Registration Certificates

🌟 Xiaorong Zhu is a dedicated physician in training, passionate about advancing patient care and mastering clinical skills in Internal Medicine. 🌿👩‍⚕️

✨Conclusion🎯

👩‍⚕️In summary, Xiaorong Zhu is a driven and skilled emerging physician with a strong foundation in Clinical Medicine and Internal Medicine. With hands-on experience in diverse medical fields, including rotations and resident training at Baotou City Central Hospital, she has developed expertise in clinical diagnosis and advanced procedures like bone marrow biopsies. Her leadership roles in academic and volunteer initiatives further demonstrate her dedication to the medical field and commitment to improving patient care. As Xiaorong continues her journey, she is poised to make significant contributions to the healthcare community. 🌟💉.

 

📊🔬NOTABLE PUBLICATION:

 

    • Function of NLRP3 inflammasome activation in multiple myeloma
      • Authors: Xiaorong Zhu, Jie Yu, Mingqiang Hua, Ning Xu, Lianjuan Wang, Lingkai Chen, Yanhong Jia, Xueyun Zhao
        Journal: Hematology
        Year: 2024

Dr. Yuta Yamanaka | Lung Cancer | Best Researcher Award

Posted on by Pencis

Dr. Yuta Yamanaka | Lung Cancer | Best Researcher Award

Kansai Medical University Hospital | Japan

AUTHOR PROFILE

Scopus

ORCID Id

🧑‍🎓 EARLY ACADEMIC PURSUITS 📚

Dr. Yuta Yamanaka embarked on his medical journey with a deep interest in oncology, focusing particularly on thoracic diseases. He completed his Medical Degree from a prestigious Japanese university, demonstrating a clear passion for cancer research, specifically targeting lung cancer. His early education laid a robust foundation in both clinical medicine and research methodologies, setting the stage for his future breakthroughs in thoracic oncology.

🩺 PROFESSIONAL ENDEAVORS 🏥

Dr. Yamanaka is a renowned thoracic oncologist at Kansai Medical University Hospital, one of Japan’s leading institutions for cancer treatment. His medical career is marked by his dedication to patient care, coupled with his pursuit of cutting-edge research in lung cancer. As a departmental leader, Dr. Yamanaka has played a crucial role in developing new protocols for the management and treatment of thoracic malignancies. His efforts have enhanced both the clinical approach and patient outcomes at the hospital.

🔬 CONTRIBUTIONS AND RESEARCH FOCUS ON LUNG CANCER🔍

Dr. Yamanaka’s primary research focus is on lung cancer, particularly in the early detection, diagnosis, and treatment of this aggressive disease. He is actively involved in clinical trials exploring novel therapeutic strategies, including targeted therapies and immunotherapy. His research has contributed to the development of new approaches to personalize treatment for lung cancer patients, making strides in precision oncology.

Additionally, Dr. Yamanaka has worked on improving the understanding of tumor biology in thoracic cancers and has published extensively on the molecular mechanisms underlying lung cancer progression.

🌍 IMPACT AND INFLUENCE 💡

Dr. Yamanaka’s work has not only impacted the lives of his patients but has also influenced the broader field of thoracic oncology. His clinical trials have pushed the boundaries of what is possible in lung cancer treatment, helping to establish new standards of care. Moreover, his contributions to the understanding of lung cancer at a molecular level have provided other researchers with critical insights, fostering global collaborations.

🏆 ACADEMIC CITES AND RECOGNITION 📜

Dr. Yamanaka has been widely cited in prestigious oncology journals for his pioneering work on lung cancer. His research has garnered international recognition, with citations numbering in the thousands, reflecting his influence in both clinical and academic spheres. He frequently presents his findings at global oncology conferences and serves as a reviewer for leading medical journals.

🔮 LEGACY AND FUTURE CONTRIBUTIONS 🌟

Looking forward, Dr. Yamanaka is poised to continue his groundbreaking work in thoracic oncology. His future research is expected to delve deeper into early-stage lung cancer detection, with the goal of significantly improving survival rates. He remains dedicated to exploring new frontiers in personalized medicine and further enhancing treatment outcomes for lung cancer patients through novel therapeutics and multimodal therapies.

Dr. Yamanaka’s legacy will undoubtedly be marked by his relentless pursuit of innovation and excellence in the treatment of thoracic cancers, securing his place as a leading figure in the global fight against lung cancer.

Dr. Yuta Yamanaka’s work in the field of lung cancer research and clinical care makes him a vital contributor to both Japanese and international oncology communities. His dedication continues to shape the future of thoracic oncology, with the promise of many more contributions to come.

✨ CONCLUSION 🎯

Dr. Yuta Yamanaka stands as a trailblazer in the field of thoracic oncology, particularly in his groundbreaking research and clinical advancements in lung cancer. His early academic pursuits laid a solid foundation for an impressive career marked by innovation, dedication, and compassion. As a respected leader at Kansai Medical University Hospital, his efforts in advancing targeted therapies, improving patient outcomes, and deepening the global understanding of lung cancer have left an indelible mark on both the medical community and the lives of countless patients.

 

📊🔬NOTABLE PUBLICATION:

 

    • Clinical significance of factor XIII activity and monocyte-derived microparticles in cancer patients
      • Authors: Sawai, Y., Yamanaka, Y., Nomura, S.
      • Journal: Vascular Health and Risk Management
      • Year: 2020

     

    • Age-Stratified Analysis of First-Line Chemoimmunotherapy for Extensive-Stage Small Cell Lung Cancer: Real-World Evidence from a Multicenter Retrospective Study
      • Authors: Takeda, T., Yamada, T., Kunimatsu, Y., Kurata, T., Takayama, K.
      • Journal: Cancers
      • Year: 2023

     

    • Multicenter Pharmacokinetic and Pharmacodynamic Study of Pembrolizumab for Non-small-Cell Lung Cancer in Patients Aged 75 Years and Older
      • Authors: Yagishita, S., Yamanaka, Y., Kurata, T., Mizugaki, H., Hamada, A.
      • Journal: Clinical Pharmacology and Therapeutics
      • Year: 2024

     

    • Paraneoplastic Neurological Syndrome-associated Antibody-positive Small-cell Lung Cancer Diagnosed with Preceding Neurological Symptoms: a Case Series 
      • Authors: Okazaki, Y., Yoshioka, H., Kamisako, K., Yamanaka, Y., Kurata, T.
      • Journal: Japanese Journal of Lung Cancer
      • Year: 2024

     

    • Investigation of a practical assessment index to capture the clinical presentation of cachexia in patients with lung cancer
      • Authors: Katsushima, U., Hase, K., Fukushima, T., Imai, Y., Kurata, T.
      • Journal: Japanese Journal of Clinical Oncology
      • Year: 2024

Dr. Takeshi Yoshimoto | Stroke with Cancer | Best Researcher Award

Posted on by Pencis

Dr. Takeshi Yoshimoto | Stroke with Cancer | Best Researcher Award

University of Tsukuba Hospital | Japan

Author Profile

Scopus

ORCID Id

Dr. Takeshi Yoshimoto 🧠💉

🔬 Research Interests

Dr. Takeshi Yoshimoto is a dedicated researcher and clinician focused on advancing stroke treatment through cutting-edge translational research. His work centers on:

  • Development of algorithms for clot removal devices in acute stroke by rapidly identifying genetic variations and serum biomarkers.
  • Exploration of juvenile stroke and its association with the RNF213 p.R4810K polymorphism linked to Moyamoya disease.
  • Innovative stroke therapies aimed at improving patient outcomes.

🎓 Education

  • Ph.D. in Biomedical and Health Sciences – Hiroshima University, Japan (August 2022)
  • M.D. – Hiroshima University Faculty of Medicine, Japan (March 2008)

💼 Professional Experience

  • April 2024 – Present: Lecturer, Department of Stroke and Cerebrovascular Diseases, University of Tsukuba Hospital
  • August 2018 – March 2024: Medical Doctor, Department of Neurology, National Cerebral and Cardiovascular Center
  • April 2018 – July 2018: Senior Resident, Department of Neurology, National Cerebral and Cardiovascular Center
  • April 2015 – March 2018: Resident, Department of Neurology, National Cerebral and Cardiovascular Center
  • April 2013 – March 2015: Neurologist, Ota Memorial Hospital
  • April 2012 – March 2013: Neurologist, Hiroshima University Graduate School of Biomedical & Health Sciences
  • April 2009 – March 2012: Intern, Fukushima Coop Hospital

🏆 Honors & Awards

  • Outstanding Presentation Award, Cardiovascular Stroke Society of Japan (2022)
  • Paul Dudley White International Scholar Award, American Heart Association (2021)
  • Outstanding Paper Award, Japanese Society of Neuroendovascular Therapy (2021)
  • Teaching Award, National Cerebral and Cardiovascular Center (2019)
  • Multiple awards for oral presentations at the Japan Stroke Society Annual Meetings (2019, 2022)

📊 Research Grants

Dr. Yoshimoto has successfully led several grant-funded projects, including:

  • Development of selection algorithms for clot removal devices in acute stroke (JSNET, 2019–2026)
  • Novel cerebrovascular treatment via SIRT1 gene activation (Japan Heart Foundation, 2020–2022)

🌐 Key Research Support

  • 2024–2026: Grant-in-Aid, JSNET – Development of selection algorithm for clot removal devices (1,000,000 JPY)
  • 2020–2022: Grant-in-Aid, Japan Heart Foundation – Novel treatments for cerebrovascular disorders (2,000,000 JPY)

✨ Conclusion

Dr. Takeshi Yoshimoto is a leading neurologist and researcher with a profound dedication to advancing the treatment of stroke and cerebrovascular diseases. His work, combining clinical expertise with innovative translational research, is driving new developments in the rapid diagnosis and treatment of acute stroke. Through his focus on genetic variations and novel therapeutic methods, Dr. Yoshimoto is shaping the future of stroke care, aiming for improved outcomes for patients worldwide. His contributions, backed by numerous awards and research grants, highlight his commitment to excellence in both academic and clinical spheres.

 

📊🔬NOTABLE PUBLICATION:

 

  • Long-Term Resveratrol Intake for Cognitive and Cerebral Blood Flow Impairment in Carotid Artery Stenosis/Occlusion
    • Authors: Hattori, Y., Kakino, Y., Hattori, Y., Iida, H., Ihara, M.
    • Journal: Journal of Stroke
    • Year: 2024

 

  • RNF213 p.R4810K Variant Increases the Risk of Vasospastic Angina
    • Authors: Ishiyama, H., Tanaka, T., Yoshimoto, T., Noguchi, T., Ihara, M.
    • Journal: JACC: Asia
    • Year: 2023

 

  • Expanding the Treatable Imaging Profile in Patients with Large Ischemic Stroke: Subanalysis from a Randomized Clinical Trial
    • Authors: Inoue, M., Yoshimoto, T., Yamagami, H., Morimoto, T., Yoshimura, S.
    • Journal: Stroke
    • Year: 2024

 

  • REsveratrol for VAscular Cognitive Impairment Investigating Cerebral Metabolism and Perfusion (REVAMP trial): A Study Protocol for a Randomized, Double-Blind, Placebo-Controlled Trial
    • Authors: Hattori, Y., Minami, M., Omae, K., Iida, H., Ihara, M.
    • Journal: Frontiers in Nutrition
    • Year: 2024

 

  • Association of Thyroid Peroxidase Antibody with the RNF213 p.R4810K Variant in Ischemic Stroke/Transient Ischemic Attack
    • Authors: Yoshimoto, T., Ishiyama, H., Hattori, Y., Koga, M., Ihara, M.
    • Journal: Atherosclerosis
    • Year: 2023

Dr. Wang Tian | Neck Cancer | Best Researcher Award

Posted on by Pencis

Dr. Wang Tian | Neck Cancer | Best Researcher Award

Fudan University | China

AUTHOR PROFILE

Scopus

🎓 EARLY ACADEMIC PURSUITS

Dr. Wang Tian embarked on his academic journey in the field of medical sciences, specializing in Otolaryngology with a focus on Head and Neck Oncology. His foundational education was marked by excellence, having graduated from one of China’s top medical institutions. He further pursued specialized training in Head and Neck Surgery, equipping himself with cutting-edge knowledge and skills. His early research was primarily centered on the identification and treatment of head and neck malignancies, laying the groundwork for a career dedicated to innovation in cancer therapy.

🏥 PROFESSIONAL ENDEAVORS

Dr. Tian is currently the Head of the Department of Head and Neck Oncology at the EENT Hospital of Fudan University, a premier institution for Ear, Nose, Throat, and specialized oncology treatments in China. Under his leadership, the department has become a hub for advanced clinical care and groundbreaking research. He is actively involved in surgical oncology, leading numerous high-risk procedures and developing new treatment protocols for cancers of the head, neck, and thyroid. His professional endeavors extend to collaborations with international oncology boards and contributing to the establishment of global best practices in the field.

💡 CONTRIBUTIONS AND RESEARCH FOCUS ON NECK CANCER

Dr. Wang Tian’s contributions to medical science, particularly in head and neck oncology, are vast and influential. His research primarily focuses on early detection, personalized treatment strategies, and minimally invasive surgical techniques. One of his notable achievements is the development of targeted therapy approaches that enhance the efficacy of traditional treatments like radiotherapy and chemotherapy. He has also contributed significantly to the study of immunotherapy for head and neck cancers, paving the way for more personalized, patient-centered treatment regimens.

🌍 IMPACT AND INFLUENCE

Dr. Tian’s work has had a profound impact on the field of oncology, both in China and globally. His research papers, published in prestigious international journals, have been widely cited and have influenced treatment protocols worldwide. He has also mentored numerous young surgeons and oncologists, many of whom have gone on to make significant contributions in their own right. His leadership at EENT Hospital has solidified the institution’s reputation as a leader in cancer treatment, particularly for complex head and neck cases.

📚 ACADEMIC CITATIONS

Dr. Wang Tian’s research has been cited extensively in academic literature, particularly in the fields of oncology, surgery, and immunotherapy. His most highly cited works pertain to innovations in head and neck cancer treatment, especially regarding new surgical techniques and personalized therapy models. His h-index reflects a significant influence in the academic and medical community, demonstrating his role as a leading expert in his field.

🏅 LEGACY AND FUTURE CONTRIBUTIONS

Dr. Wang Tian’s legacy is one of innovation, dedication, and a commitment to improving patient outcomes. He is regarded as a pioneer in head and neck cancer treatment, with a long-standing impact that will influence future generations of oncologists and surgeons. Looking forward, Dr. Tian continues to push the boundaries of research in cancer immunotherapy and genetic-based treatments, with an eye on developing even more effective and less invasive therapeutic options. His ongoing work promises to further revolutionize the field and offer hope to patients worldwide.

🔔 CONCLUSION

Dr. Wang Tian stands as a prominent figure in the realm of head and neck oncology, with his contributions significantly shaping both clinical practices and research directions. From his early academic pursuits to his leadership at the EENT Hospital of Fudan University, his commitment to advancing cancer treatments is evident. Dr. Tian’s innovative research in targeted therapies, immunotherapy, and minimally invasive surgery has not only improved patient outcomes but also set new standards in oncology care. His legacy, marked by mentorship, extensive publications, and groundbreaking discoveries, continues to inspire future generations. As he moves forward, his future contributions will likely lead to even more transformative breakthroughs, cementing his place as a global leader in head and neck cancer treatment.

 

📊🔬NOTABLE PUBLICATION:

 

  • Title: The role of systemic inflammatory response index (SIRI) and tumor-infiltrating lymphocytes (TILs) in the prognosis of patients with laryngeal squamous cell carcinoma
    Authors: Wang, T., Zhang, D., Tang, D., Lu, L.-M., Tao, L.
    Journal: Journal of Cancer Research and Clinical Oncology
    Year: 2023

 

  • Title: Peripheral lymphocyte count as an indicator of radiotherapy effectiveness in hypopharyngeal squamous cell carcinoma
    Authors: Lin, H., Gao, C., Heng, Y., Wu, C., Tao, L.
    Journal: Clinical Otolaryngology
    Year: 2024

 

  • Title: Neoadjuvant chemotherapy for organ preservation in sinonasal squamous cell carcinoma
    Authors: Wang, T., Li, Y., Wang, L., Zhao, K., Song, X.
    Journal: European Archives of Oto-Rhino-Laryngology
    Year: 2024

 

  • Title: Camrelizumab-based induction chemoimmunotherapy in locally advanced stage hypopharyngeal carcinoma: phase II clinical trial
    Authors: Gong, H., Tian, S., Ding, H., Wang, S., Zhou, L.
    Journal: Nature Communications
    Year: 2024

 

  • Title: Surgery for adult head and neck rhabdomyosarcoma: A retrospective report from one institution
    Authors: Wang, T., Wang, J., Tang, T., Li, Y., Song, X.
    Journal: International Forum of Allergy and Rhinology
    Year: 2024

Assoc Prof Dr. Han Xiong | Physical Medicine | Best Researcher Award

Posted on by Pencis

Assoc Prof Dr. Han Xiong | Physical Medicine | Best Researcher Award

Chongqing University | China

AUTHOR PROFILE

Scopus

ORCID Id

🏫 EARLY ACADEMIC PURSUITS

Dr. Han Xiong completed his Ph.D. in Radio Physics at the University of Electronic Science and Technology of China in 2014. During his doctoral studies, he participated in an academic visit to the University of Houston, USA, in 2013. This visit expanded his academic exposure and laid the groundwork for his future research endeavors.

💼 PROFESSIONAL ENDEAVORS

Following his graduation, Dr. Xiong began his professional career at the School of Microelectronics and Communication Engineering, Chongqing University, from July 2014 to September 2020. During this period, he honed his teaching and research skills in antenna theory and microwave technology. In October 2020, he transitioned to the School of Electrical Engineering at the same university, where he currently serves as an Associate Professor and Master’s Student Supervisor. Dr. Xiong has taken a leadership role in various research projects funded by the National Natural Science Foundation, Chongqing University, and national defense programs.

🔬 CONTRIBUTIONS AND RESEARCH FOCUS ON PHYSICAL MEDICINE

Dr. Xiong’s primary research areas are wireless power transfer and absorbing material theoretical research, with a focus on metamaterials, graphene absorbers, and radar stealth technology. His research has led to substantial advancements in the microwave field, particularly in antenna theory and metamaterials. His work in microwave wireless power transmission is especially noteworthy. He has published over 70 academic papers, including more than 50 SCI-indexed papers in prestigious journals such as Applied Physics Letters and OpticsExpress.

🌍 IMPACT AND INFLUENCE

Dr. Xiong has made significant contributions to the academic community. He is a regular reviewer for high-impact journals, including the Journal of Applied Physics, Carbon, and the Applied Computational Electromagnetic Society (ACES). His expertise in the field of microwave engineering and metamaterials is widely recognized, making him a valuable contributor to the global academic discourse on electromagnetic fields and waves.

📚 ACADEMIC SERVICE AND TEACHING

Dr. Xiong is also dedicated to teaching, currently offering the undergraduate course Electromagnetic Fields and Waves. His commitment to education has helped shape the next generation of electrical engineers, equipping them with a strong foundation in theoretical and practical aspects of electromagnetic phenomena.

🏆 AWARDS AND RECOGNITION

Dr. Xiong’s work has earned him accolades, most notably the First Prize for Innovation in Invention and Entrepreneurship for his project titled Key Technologies and Applications of Microwave Wireless Power Transmission in 2023. This award underscores his leadership in wireless power transmission technology and reflects his collaborative success alongside notable colleagues such as Zhang Huaiqing, Wang Xin, Su Dongping, Xiao Hui, and Xiao Dongping.

📈 LEGACY AND FUTURE CONTRIBUTIONS

Dr. Xiong has established a remarkable academic legacy with 17 patent applications to his name, showcasing his innovative approach to microwave and wireless power technologies. His ongoing research is expected to contribute further to advancements in wireless power transfer, metamaterials, and microwave stealth technology. As he continues to lead and participate in cutting-edge projects, his influence on both academic research and practical applications will undoubtedly leave a lasting impact on the field of electrical engineering.

🏅 CONCLUSION

Dr. Han Xiong stands out as a dedicated researcher, educator, and innovator in the fields of wireless power transfer, metamaterials, and microwave technology. With a strong foundation from his early academic years and a career that has spanned impactful research and teaching, he has made significant strides in advancing both theoretical and applied aspects of electrical engineering. His numerous publications, patent applications, and leadership in key projects demonstrate his influence and expertise in the field. As he continues to break new ground in emerging technologies, Dr. Xiong’s contributions will shape future innovations and inspire the next generation of engineers and scientists. His legacy, marked by substantial research achievements and academic service, ensures that his work will have a long-lasting impact on both industry and academia.

 

📊🔬NOTABLE PUBLICATION:

 

  • Design and Analysis of an Electromagnetic Energy Conversion Device
    • Authors: Xiong, H., Ma, X., Wang, B.-X., Zhang, H.
    • Journal: Sensors and Actuators A: Physical
    • Year: 2024

 

  • A Metamaterial Energy Power Detector Based on Electromagnetic Energy Harvesting Technology
    • Authors: Xiong, H., Deng, J., Yang, Q., Wang, X., Zhang, H.
    • Journal: ACS Applied Electronic Materials
    • Year: 2024

 

  • Design of Energy-Selective Surface with an Ultra-wide Shielding Band for High-Power Microwave Protection
    • Authors: Xiong, H., Suo, M., Li, X., Xiao, D., Zhang, H.
    • Journal: ACS Applied Electronic Materials
    • Year: 2024

 

  • Ultra-Wideband Low-RCS Circularly Polarized Antennas Realized by Bilayer Polarization Conversion Metasurfaces and Novel Feeding Networks
    • Authors: Gao, X., He, L.Y., Yin, S.J., Cheng, Q., Cui, T.J.
    • Journal: IEEE Transactions on Antennas and Propagation
    • Year: 2024

 

  • The Construction of Versatile Terahertz Metamaterial Having Tunable Dual-Band Electromagnetically Induced Transparency Based on Two Falling Asymmetric T-Shaped Graphene Resonators
    • Authors: Duan, G., Chen, Y., Zhu, H., Xu, N., Wang, B.-X.
    • Journal: Optics and Laser Technology
    • Year: 2024